Knowledge Hub

Add resource

8508 matches found

P5-2 What is the current state of dengue vaccine development and new technologies?

Global initiatives Dengue

P5-1 Overview of arbovirus vaccines

Global initiatives

L'introduction de la dose d'hépatite B à la naissance - Liste de contrôle pour l'analyse de la situation et Outil d'évaluation de l'état de préparation

Programme management Hepatitis B

P4-4 Vaccine efficacy evidence generation in outbreaks

Global initiatives

P4-3 A systematic approach to identification of correlates of protection

Global initiatives

P4-2 Clinical immunobridging strategy to support licensure of preventive vaccines

Global initiatives

P4-1 Introduction: Why is innovation in clinical trials needed now?

Global initiatives

Hepatitis B Birth Dose Introduction - Situation Analysis Checklist and Readiness Assessment Tool

Programme management Hepatitis B

P3-3 The CEPI R&D Funding Model

Global initiatives

P3-2 The infectious diseases vaccines R&D financing landscape​: An Industrial perspective​

Global initiatives

P3-1 The Value of Health R&D –The Return on Investment

Global initiatives

P2-4 Development of vaccines for global use: Role of the vaccine industry

Global initiatives

P2-3 Setting R&D Priorities – Bio-Manguinhos’ Perspectives

Global initiatives

P2-2 Prioritizing pathogens with epidemic and pandemic potential

Global initiatives

P2-1 Pathogen prioritization at the global level: WHO Global Priority Endemic Pathogens for Vaccine R&D

Global initiatives

P1-4 Vaccination overview in Brazil

Global initiatives Brazil

P1-3 Delivering vaccines: Vaccine innovation ecosystem past, present, and future

Global initiatives

P1-2 Innovation in vaccine development

Global initiatives

P1-1 Innovations in vaccine discovery

Global initiatives

Statement on Rotarix® and Vaccine Vial Monitor (VVM) compliance

Vaccines & delivery devices Rotavirus

Filters